Year Founded
2009
Ownership
Private
Therapeutic Areas
OtherGastroenterology
Stage
Commercial
Modalities
Small moleculeProtein therapeuticsOther

Nivagen Pharmaceuticals General Information

Nivagen Pharmaceuticals is a commercial-stage pharmaceutical company that recently sold its MedisourceRx business unit.

Contact Information

Website
Primary Industry
[ "Pharma" ]
Corporate Office

Drug Pipeline

No pipeline data available

For full access to Nivagen Pharmaceuticals's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Nivagen Pharmaceuticals Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Nivagen Pharmaceuticals's complete valuation and funding history, request access »

Nivagen Pharmaceuticals Investors

BizCap
Investor Type: Venture Capital
Holding: Minority
Telegraph Hill Partners
Investor Type: Venture Capital
Holding: Minority
Paycheck Protection Program
Investor Type: Venture Capital
Holding: Minority